99mTc-methyl-CCNU for the static imaging of kidneys

Area of Science:

• Nuclear medicine
• Radiopharmacology
• Diagnostic imaging

Background:

• Static kidney imaging requires effective radiopharmaceuticals.
• Evaluating new agents for renal diagnostics is crucial.

Purpose of the Study:

• To prepare and evaluate 99mTc-Methyl-CCNU as a novel radiopharmaceutical for static kidney imaging.
• To assess its radiochemical purity, biological distribution, and clinical utility.

Main Methods:

• Radiopharmaceutical preparation and purity testing using chromatography.
• Biological distribution studies in mice post-intravenous injection.
• Pharmacokinetic analysis in human volunteers (blood clearance, urinary excretion).
• Autoradiography and scintigraphy of rabbit kidney slices.

Main Results:

• High renal uptake (25% within 6 hours) and rapid plasma clearance (90% within 1 hour).
• Urinary excretion plateaued at 25% after 6 hours.
• Autoradiography and scintigraphy confirmed cortical accumulation in rabbit kidneys.
• Clinical studies demonstrated its utility for kidney imaging.

Conclusions:

• 99mTc-Methyl-CCNU is a promising radiopharmaceutical for static kidney imaging.
• Its pharmacokinetic profile supports effective renal visualization.
• Further clinical application for kidney diagnostics is indicated.